Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.
Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder…
Tears in the shoulder’s rotator cuff, a common sports injury, are painful and restricting. Surgery to repair the damage is successful for pain management, but in many patients it does not result in full recovery of function due to poor healing. New research shows an approved therapy for osteoporosis, Forteo, may speed healing and improve patient outcomes.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.
Using newly affordable technology, researchers at the University of Utah and other institutions have sequenced for the first time the entire genome of a family.
SPOKANE, Wash.—-Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.
They were blessed with a daughter, Ng Xin Yuen, in 2007 but that was also when their heartache and nightmare began. “She looked like a perfectly healthy baby when she was born. But when she was 3 mont…
A single session of heat therapy using the ThermoMed device appears to be as effective as a 10-day intravenous course of sodium stibogluconate (Pentostam) for the treatment of Leishmania major skin lesions, according to a new study by Naomi Aronson and her colleagues at the Uniformed Services University of the Health Sciences and Walter Reed Army Medical Center (WRAMC).
For 25 years, scientists have touted the promise of gene therapy to treat human diseases, but only a handful of therapies have shown progress. Nonetheless, proponents remain optimistic and say the approach may yet revolutionize medicine.
Dr. Marc McKee, of McGill’s Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee’s research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth. While osteoporosis later …
March 5 (Bloomberg) — CSL Ltd., the world’s second-biggest maker of treatments derived from blood, won U.S. clearance to sell a weekly immune-replacement therapy for people with genetic disorders that lead to frequent infections.
March 4 (Bloomberg) — CSL Ltd. won U.S. clearance to sell a weekly immune-replacement therapy for people with genetic disorders that cause frequent infections.
March 5 (Bloomberg) — CSL Ltd. in Australian trading rose to the highest in more than a year after it won U.S. clearance to sell a weekly immune-replacement therapy for people with genetic disorders that lead to frequent infections.
March 5 (Bloomberg) — CSL Ltd. , the world’s second-biggest maker of treatments derived from blood, won U.S. clearance to sell a weekly immune-replacement therapy for people with genetic disorders that lead to frequent infections.
When people get exposed to the mycobacterium responsible for tuberculosis, some will become sick with a disease that is a major cause of mortality around the world while others simply don’t. Now, researchers can point to one important reason for this variation in susceptibility or resistance. It turns out individuals with a certain genetic variation are less likely to succumb to tuberculosis …
Local researchers have found that genetic therapy can reverse the effects of a fatal childhood muscular disorder.
C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional …
Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.This muscle-wasting disease results when a child’s motor neurons – nerve cells that send signals from the spinal cord to muscles – produce insufficient amounts of what …
The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.
Scientists at Ohio State University say that a lethal childhood disorder spinal muscular atrophy may be susceptible to effective treatment through gene therapy.
Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.
Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.
( Ohio State University ) Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows. This muscle-wasting disease results when a child’s motor neurons — nerve cells that send signals from the spinal cord to muscles — produce …
Imagine scientists hiding a genetic code inside of a virus and then they use that virus to infect the brain. The goal: to essentially deprogram Parkinson’s disease. The idea is not that far fetched and in fact the experimental therapy is now underway in the Bay Area.